Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
789 studies found for:    Open Studies | "Pancreatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis
Condition: Chronic Pancreatitis
Interventions: Dietary Supplement: Vitamin D 100ug;   Dietary Supplement: Vitamin D 10ug
22 Not yet recruiting COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis
Condition: Pancreatitis, Acute
Interventions: Drug: Cox-2;   Drug: Indomethacin
23 Recruiting Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography
Condition: Pancreatitis, Acute
Interventions: Drug: Epinephrine;   Other: Sterile water;   Drug: Indomethacin Rectal Suppository
24 Recruiting Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
Condition: Chronic Pancreatitis
Interventions: Drug: Prolastin-C;   Drug: Placebo
25 Recruiting The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
Condition: Acute Pancreatitis
Intervention: Procedure: ERCP
26 Recruiting Imipenem Prophylaxis in Patients With Acute Pancreatitis
Condition: Acute Pancreatitis
Interventions: Drug: Imipenem;   Drug: Placebo
27 Recruiting Treatment of Acute Pancreatitis With Ketorolac
Condition: Acute Pancreatitis
Interventions: Drug: Ketorolac;   Drug: Placebo
28 Recruiting MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics
Condition: Healthy Volunteers
Intervention: Drug: Secretin
29 Recruiting Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis
Condition: Post-ERCP Acute Pancreatitis
Interventions: Drug: epinephrine;   Drug: normal saline
30 Recruiting ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP
Condition: Post-ERCP Acute Pancreatitis
Interventions: Procedure: EST+LBD+ENBD;   Procedure: EST+LBD
31 Recruiting Aggressive Fluid Hydration for the Prevention of Post-ERCP Pancreatitis
Condition: Pancreatitis
Intervention: Drug: Lactated Ringer's solution
32 Recruiting Early Feeding in Acute Pancreatitis in Children
Condition: Acute Pancreatitis
Intervention: Other: Early enteral feeding
33 Recruiting Enhanced Recovery in Acute Pancreatitis
Condition: Acute Pancreatitis
Intervention: Other: Enhanced recovery protocol
34 Recruiting Rectal Indomethacin to Prevent Post ESWL-pancreatitis
Condition: Pancreatitis
Interventions: Drug: indomethacin suppository;   Drug: glycerin suppository
35 Recruiting Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
Conditions: Mesenchymal Tumor;   Autoimmune Pancreatitis;   Lymphoma;   Solid Tumors
Interventions: Procedure: EUS-FNB with ProCore needle;   Procedure: EUS-FNB with SharkCore needle;   Device: ProCore needle;   Device: SharkCore needle
36 Recruiting Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis
Conditions: Acute Pancreatitis;   Chronic Pancreatitis;   Recurrent Disease
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Simvastatin
37 Not yet recruiting Anti-inflammatory Therapy to Improve Outcomes After TPIAT
Condition: Pancreatitis, Chronic; Diabetes; Transplant
Interventions: Drug: etanercept;   Drug: Alpha 1-Antitrypsin
38 Recruiting Fluid Resuscitation in Acute Pancreatitis
Condition: Pancreatitis
Intervention: Drug: Ringer lactate
39 Not yet recruiting Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis
Condition: Pancreatitis
Interventions: Drug: Pancrelipase;   Drug: placebo
40 Recruiting A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Condition: Chronic Pancreatitis
Interventions: Drug: NI-03;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.